Shortage Watch Free FDA drug-shortage watch

← all medications

Triamcinolone Acetonide Injection

Brand names: Triesence

Category: Ophthalmology

Not specified 1

FDA status: Resolved · Last FDA update: Jul 31, 2026 · First posted: Sep 27, 2021 · 1 manufacturers, 1 listed presentations

As of Jul 31, 2026, the FDA lists Triamcinolone Acetonide Injection as shortage resolved. Of 1 manufacturer presentations, 1 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Triamcinolone Acetonide Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
Triesence, Injection, 40 mg/1 mL (NDC 82667-800-01)
NDC 82667-800-01		 Harrow Eye, LLC Not specified -

Related medications in shortage

Other Ophthalmology medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Triamcinolone Acetonide Injection (FDA data as of Jul 31, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Triamcinolone Acetonide Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Triamcinolone Acetonide Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/triamcinolone-acetonide-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).